5 news items
Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
BREA
CELZ
DIS
8 Mar 24
and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS
ARDX
DYAI
MEDS
28 Feb 24
an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
MRVI
22 Feb 24
cause its operating results to fall below expectations or any guidance provided.Natural
Earnings Scheduled For February 22, 2024
KYMR
L
LASR
22 Feb 24
) is likely to report quarterly loss at $0.12 per share on revenue of $37.69 million.
• Pioneer Natural Resources
TriLink BioTechnologies, A Maravai LifeSciences Company Solidifies IP Position With Awarded Patents For CleanCap Capping Technology In China And Canada
MRVI
21 Feb 24
the production of mRNAs containing the major natural cap structures found in humans, a significant improvement over legacy capping methods such as enzymatic
- Prev
- 1
- Next